Sign in
4

Changes in Ownership

Sionna Therapeutics, Inc. Filed Acc 0001451612-26-000008

Options or other derivatives

  • Director acquired 17,340 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Booth Bruce Director 2026-06-17 Grant or award · Non-Qualified Stock Option (right to buy) +17,340 17,340 D: show line 1 in the form
Loading xslF345X06/edgardoc.xml…